206 related articles for article (PubMed ID: 27840982)
1. Annexin A1 is involved in resistance to 5-FU in colon cancer cells.
Onozawa H; Saito M; Saito K; Kanke Y; Watanabe Y; Hayase S; Sakamoto W; Ishigame T; Momma T; Ohki S; Takenoshita S
Oncol Rep; 2017 Jan; 37(1):235-240. PubMed ID: 27840982
[TBL] [Abstract][Full Text] [Related]
2. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
Ghosh S; Singh R; Vanwinkle ZM; Guo H; Vemula PK; Goel A; Haribabu B; Jala VR
Theranostics; 2022; 12(12):5574-5595. PubMed ID: 35910798
[TBL] [Abstract][Full Text] [Related]
3. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.
Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Enoki T; Li TS; Hamano K
J Cell Mol Med; 2015 Jul; 19(7):1569-81. PubMed ID: 25689483
[TBL] [Abstract][Full Text] [Related]
4. Beta-Hydroxybutyrate Promotes Proliferation, Migration and Stemness in a Subpopulation of 5FU Treated SW480 Cells: Evidence for Metabolic Plasticity in Colon Cancer.
Shakery A; Pourvali K; Ghorbani A; Fereidani SS; Zand H
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3287-3294. PubMed ID: 30486639
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
[TBL] [Abstract][Full Text] [Related]
7. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo.
Zhang Z; Huang L; Zhao W; Rigas B
Cancer Res; 2010 Mar; 70(6):2379-88. PubMed ID: 20215502
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.
Suetsugu T; Mori R; Futamura M; Fukada M; Tanaka H; Yasufuku I; Sato Y; Iwata Y; Imai T; Imai H; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yoshida K
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649846
[TBL] [Abstract][Full Text] [Related]
9. ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway.
Wang Z; Zhao X; Wang W; Liu Y; Li Y; Gao J; Wang C; Zhou M; Liu R; Xu G; Zhou Q
Int J Oncol; 2018 Nov; 53(5):2102-2110. PubMed ID: 30106136
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells.
González-Vallinas M; Molina S; Vicente G; de la Cueva A; Vargas T; Santoyo S; García-Risco MR; Fornari T; Reglero G; Ramírez de Molina A
Pharmacol Res; 2013 Jun; 72():61-8. PubMed ID: 23557932
[TBL] [Abstract][Full Text] [Related]
11. Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil.
Ravizza R; Molteni R; Gariboldi MB; Marras E; Perletti G; Monti E
Eur J Cancer; 2009 Mar; 45(5):890-8. PubMed ID: 19171477
[TBL] [Abstract][Full Text] [Related]
12. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.
Touil Y; Igoudjil W; Corvaisier M; Dessein AF; Vandomme J; Monté D; Stechly L; Skrypek N; Langlois C; Grard G; Millet G; Leteurtre E; Dumont P; Truant S; Pruvot FR; Hebbar M; Fan F; Ellis LM; Formstecher P; Van Seuningen I; Gespach C; Polakowska R; Huet G
Clin Cancer Res; 2014 Feb; 20(4):837-46. PubMed ID: 24323901
[TBL] [Abstract][Full Text] [Related]
13. Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.
Bizzarro V; Belvedere R; Milone MR; Pucci B; Lombardi R; Bruzzese F; Popolo A; Parente L; Budillon A; Petrella A
Oncotarget; 2015 Sep; 6(28):25076-92. PubMed ID: 26312765
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5.
Guzmán-Aránguez A; Olmo N; Turnay J; Lecona E; Pérez-Ramos P; López de Silanes I; Lizarbe MA
J Cell Biochem; 2005 Jan; 94(1):178-93. PubMed ID: 15526283
[TBL] [Abstract][Full Text] [Related]
15. The effects of 5-fluorouracil on the proteome of colon cancer cells.
Marin-Vicente C; Lyutvinskiy Y; Romans Fuertes P; Zubarev RA; Visa N
J Proteome Res; 2013 Apr; 12(4):1969-79. PubMed ID: 23477467
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of phytoestrogens in inducing cell death mediated by decreasing Annexin A1 in Annexin A1-knockdown leukemia cells.
Hasan M; Kumolosasi E; Jasamai M; Jamal JA; Azmi N; Rajab NF
Daru; 2020 Jun; 28(1):97-108. PubMed ID: 31912375
[TBL] [Abstract][Full Text] [Related]
17. NFκB-Associated Pathways in Progression of Chemoresistance to 5-Fluorouracil in an In Vitro Model of Colonic Carcinoma.
Körber MI; Staribacher A; Ratzenböck I; Steger G; Mader RM
Anticancer Res; 2016 Apr; 36(4):1631-9. PubMed ID: 27069140
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
[TBL] [Abstract][Full Text] [Related]
19. Upregulated Annexin A1 promotes cellular invasion in triple-negative breast cancer.
Okano M; Kumamoto K; Saito M; Onozawa H; Saito K; Abe N; Ohtake T; Takenoshita S
Oncol Rep; 2015 Mar; 33(3):1064-70. PubMed ID: 25592491
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancer.
Liu QH; Yong HM; Zhuang QX; Zhang XP; Hou PF; Chen YS; Zhu MH; Bai J
Invest New Drugs; 2020 Apr; 38(2):350-359. PubMed ID: 31124054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
